332 related articles for article (PubMed ID: 1970120)
1. A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment.
Crossman AR
Mov Disord; 1990; 5(2):100-8. PubMed ID: 1970120
[TBL] [Abstract][Full Text] [Related]
2. The neural mechanisms underlying levodopa-induced dyskinesia in Parkinson's disease.
Brotchie JM
Ann Neurol; 2000 Apr; 47(4 Suppl 1):S105-12; discussion S112-4. PubMed ID: 10762137
[TBL] [Abstract][Full Text] [Related]
3. Clinical physiology of dopa dyskinesia.
Hallett M
Ann Neurol; 2000 Apr; 47(4 Suppl 1):S147-50; discussion S150-3. PubMed ID: 10762142
[TBL] [Abstract][Full Text] [Related]
4. The spectrum of levodopa-induced dyskinesias.
Fahn S
Ann Neurol; 2000 Apr; 47(4 Suppl 1):S2-9; discussion S9-11. PubMed ID: 10762127
[TBL] [Abstract][Full Text] [Related]
5. Dyskinesias and the subthalamic nucleus.
Benabid AL; Benazzouz A; Limousin P; Koudsie A; Krack P; Piallat B; Pollak P
Ann Neurol; 2000 Apr; 47(4 Suppl 1):S189-92. PubMed ID: 10762147
[TBL] [Abstract][Full Text] [Related]
6. Nondopaminergic mechanisms in levodopa-induced dyskinesia.
Brotchie JM
Mov Disord; 2005 Aug; 20(8):919-31. PubMed ID: 16007614
[TBL] [Abstract][Full Text] [Related]
7. Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine.
Lozano AM; Lang AE; Levy R; Hutchison W; Dostrovsky J
Ann Neurol; 2000 Apr; 47(4 Suppl 1):S141-6. PubMed ID: 10762141
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacology of levodopa-induced dyskinesia.
Nutt JG
Ann Neurol; 2000 Apr; 47(4 Suppl 1):S160-4; discussion S164-6. PubMed ID: 10762144
[TBL] [Abstract][Full Text] [Related]
9. Surgery for levodopa-induced dyskinesias.
Lang AE
Ann Neurol; 2000 Apr; 47(4 Suppl 1):S193-9; discussion S199-202. PubMed ID: 10762148
[TBL] [Abstract][Full Text] [Related]
10. Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification.
Luquin MR; Scipioni O; Vaamonde J; Gershanik O; Obeso JA
Mov Disord; 1992; 7(2):117-24. PubMed ID: 1350058
[TBL] [Abstract][Full Text] [Related]
11. Should levodopa be used anymore?
Zegers de Beyl D
Acta Neurol Belg; 2002 Dec; 102(4):163-6. PubMed ID: 12534242
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors.
Guigoni C; Aubert I; Li Q; Gurevich VV; Benovic JL; Ferry S; Mach U; Stark H; Leriche L; Håkansson K; Bioulac BH; Gross CE; Sokoloff P; Fisone G; Gurevich EV; Bloch B; Bezard E
Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S25-9. PubMed ID: 15885624
[TBL] [Abstract][Full Text] [Related]
13. Levodopa-induced dyskinesia: a pathological form of striatal synaptic plasticity?
Calabresi P; Giacomini P; Centonze D; Bernardi G
Ann Neurol; 2000 Apr; 47(4 Suppl 1):S60-8; discussion S68-9. PubMed ID: 10762133
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of selective D-1 and D-2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- exposed monkeys.
Blanchet P; Bédard PJ; Britton DR; Kebabian JW
J Pharmacol Exp Ther; 1993 Oct; 267(1):275-9. PubMed ID: 7901395
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of dyskinesias in Parkinson's disease.
Mouradian MM; Heuser IJ; Baronti F; Fabbrini G; Juncos JL; Chase TN
Ann Neurol; 1989 May; 25(5):523-6. PubMed ID: 2774496
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Parkinson's disease with the partial dopamine agonist EMD 49980.
Bravi D; Davis TL; Mouradian MM; Chase TN
Mov Disord; 1993 Apr; 8(2):195-7. PubMed ID: 8097280
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing the onset and persistence of dyskinesia in MPTP-treated primates.
Jenner P
Ann Neurol; 2000 Apr; 47(4 Suppl 1):S90-9; discussion S99-104. PubMed ID: 10762136
[TBL] [Abstract][Full Text] [Related]
18. Preventing and controlling dyskinesia in Parkinson's disease--a view of current knowledge and future opportunities.
Jenner P
Mov Disord; 2008; 23 Suppl 3():S585-98. PubMed ID: 18781676
[TBL] [Abstract][Full Text] [Related]
19. Preventing levodopa-induced dyskinesias.
Olanow CW; Obeso JA
Ann Neurol; 2000 Apr; 47(4 Suppl 1):S167-76; discussion S176-8. PubMed ID: 10762145
[TBL] [Abstract][Full Text] [Related]
20. L-dopa-induced dyskinesia and stereotactic surgery for Parkinson's disease.
Guridi J; Obeso JA; Rodriguez-Oroz MC; Lozano AA; Manrique M
Neurosurgery; 2008 Feb; 62(2):311-23; discussion 323-5. PubMed ID: 18382309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
